haloperidol has been researched along with ncq 298 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, I; Gustafsson, K; Westlind-Danielsson, A | 1 |
| Freccero-Rosman, K; Levander, S; Ohlsson, T; Rosén, I; Ryding, E; Sjöholm, H; Tuninger, E | 1 |
| Johnson, AE; Källström, L; Wiesel, FA; Yu, J | 1 |
3 other study(ies) available for haloperidol and ncq 298
| Article | Year |
|---|---|
Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Calcium; Colforsin; Corpus Striatum; Cyclic AMP; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; In Vitro Techniques; Male; Pergolide; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Remoxipride; Salicylamides; Structure-Activity Relationship; Sulpiride | 1994 |
Dopamine D2-receptor density in humans as assessed with SPET and the new high-affinity ligand 123I-NCQ298: a pilot study.
Topics: Adult; Aged; Antipsychotic Agents; Brain; Cerebrovascular Circulation; Dopamine Agonists; Female; Haloperidol; Humans; Iodine Radioisotopes; Male; Middle Aged; Perphenazine; Pilot Projects; Radiopharmaceuticals; Receptors, Dopamine D2; Regional Blood Flow; Salicylamides; Schizophrenia; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 1998 |
Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzazepines; Binding Sites; Binding, Competitive; Clozapine; Dopamine Agonists; Dopamine Antagonists; Entopeduncular Nucleus; Female; Glutamate Decarboxylase; Haloperidol; In Situ Hybridization; Mastication; Neostriatum; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; RNA, Messenger; Salicylamides; Time Factors | 1999 |